VTL References: 
1. Cancer Statistics 1993 (Jan-Feb) Cancer 43: 
2. Salcman M. Epidemiology and factors affecting survival. In: Apuzzo MLJ, ed. Malignant Cerebral 
Glioma. Park Ridge, 111: American Association of Neurological Surgeons, 1990; chapter 7:95-110 
3. Weir B.The relative significance of factors affecting postoperative survival in astrocytomas, grades 
3 and 4. J. Neurosurg, 1973; 38:448-52 
4. Black PM. Brain tumors. N Engl J Med 1991; 324:1471-6 and 1555-64. 
5. Mahaley SB. Neuro-oncology index and review (adult primary brain tumors).J Neuro-Oncology 
1991;11:85-147 
6. Ammirati M, Vick N, Liao YL, Ciric I, Mikhael M. Effect of the extent of surgical resection on 
survival and quality of life in patients with supratentorial glioblastomas and anaplastic 
astrocytomas. Neurosurgery 1987; 21:201-6 
7. Ciric I, Rovin R, Cozzens JW, Eller TW, Vick NA, Mikhael MA. Role of surgery in the treatment of 
malignant cerebral gliomas. In: Apuzzo MLJ, ed. Malignant Cerebral Glioma. Park Ridge, 111: American 
Association of Neurological Surgeons, 1990; chapter 10:141-155 
8. Gehan EA, Walker MD. National Cancer Institute Monograph #46, 1977; 189-195 
9. Walker MD, Green SB, Byar DP,Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, 
Mahaley MS, Mealey J, Owens G, Ransohoff H, Robertson JT, Shapiro WR, Smith KR, Wilson CB, 
Strike TA. Randomized comparisons of radiotherapy and nitrosureas for the treatment of malignant 
glioma after surgery. N. Engl J Med 1980; 303:1323-9 
10. Solero CL, Monfardini S, Brambilla C, Vaghi A, Valagussa P, Morello G, Bonadonna G. Controlled 
study with BCNU vs CCNU as adjuvant chemotherapy following surgery plus radiotherapy for 
glioblastoma multiformeCancer Clin Trials 1979; 2:43-8 
11. Walker MD, Green SB, Bryar DP. Elexander E Jr, Batsdorf U, Brooks WH, Hunt WE, MacCarty CS, 
Mahaley MS, Measley J, Owens G, Ransfohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, 
Strike TA. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant 
glioma after surgery .N Eng L Med 1980; 303:1323-9 
12. Green SB, Byar DP, Walker MD, Pistenmaa DA, Elexander E, Batzdorf U, Brooks WH, Hunt WE, 
Measley J, Odom GL, Paoletti P, Ransohoff J, Robertson JT, Seler RG, Shapiro WR, Smith KR, Wilson 
CB, Strike TA. Comparisons of carmustine, procarbazine and high-dose methylprednisolone as 
additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983; 
67:121-32 
13. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: a simple and 
reproducible method. Cancer 1988; 62:2152-2165 
14. Mahaley MS, Mettlin C, Natarajan N, Laws ER, Peace BB. National survey on patterns of care for 
brain-tumor patients.J Neurosurg 1989; 71:826-36 
15. Weir B, Grace M. The relative significance of factors affecting postoperative survival in 
astrocytomas, grades one and two. Can J Neurol Sci 1976; 3:47-50 
Recombinant DNA Research, Volume 18 
[145] 
